logo of the EU drugs agency

You are viewing archived content

Please note that this page is a static copy of a previously published web page and is no longer actively maintained.
Be aware that the information contained here may be out-of-date.
For the most recent information, we recommend visiting the main website of the EMCDDA.

Table TDI-10. Age distribution by primary drug of clients entering treatment — EU overall summary in 2006 [see all tables in this series...]

Part (iii) Percentage distribution of all outpatient clients by age group for each primary drug

Substance<1515–1920–2425–2930–3435–3940–4445+Mean ageAge known (base)Age not known
Hypnotics and sedatives0.34.410.413.515.815.512.527.536.26454181
Volatile substances20.532.523.
Cannabis 3.630.929.516.48.55.332.824.467184217
Other substances 0.97.21917.916.614.


 The countries supplying data are: 

 BG, CZ, DK, DE, IE, EL, ES, FR, IT, CY, LT, LU, HU, MT, NL, AT, SK, FI, SE, UK. 

 Last data available from Spain refer to year of treatment 2005. 

 The number of treatment clients in each country is listed in Table TDI-7

 See also Table TDI-103 on distribution by country and ‘General notes for interpreting data’ on the Explanatory notes and help page


 Reitox national reports 2007 — Table TDI outpatient and inpatient treatment centres. 

(see the help page for information about formats etc.)

Page last updated: Monday, 14 July 2008